Arcturus Therapeutics Holdings Inc ARCT shares are trading higher Wednesday after the company reported strong fourth-quarter results and provided an update on pipeline progress. Guggenheim reiterated ...
On Tuesday, Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) announced that it will present Phase 1 results in healthy volunteers and new Phase 1b interim data in cystic fibrosis (CF) for ARCT-032 at ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback